We are Buy Rated. 2024 Guide - Revenue guidance of $9,350 - 9,500 was largely in-line with our $9,431M estimate and implied growth of 5.9-7 .6% excluding future M&A. EBITDA guidance of $550 - 564M captured our EBITDA estimate (ex-M&A) of $563M. The company noted that EBITDA guidance excludes contribution from quality incentive payments, of which we include approximately $16M in our 2024 EBITDA estimates. On an underlying basis, EBITDA guidance in particular looks better than expected to us. 4Q Performance - Revenue and EBITDA were both in-line to slightly ahead of expectations. 4Q revenue of $2,375M was ahead of our estimate of $2,364M by roughly 50bps, while EBITDA of $143M was ahead of our $142M estimate. Cash flow from operations of $162M was also materially stronger than our $45M estimate, and drove full-year FCF of $137M.